FHTX
Foghorn Therapeutics Inc

589
Loading...
Loading...
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
112

Frequently Asked Questions

What is Market Cap of Foghorn Therapeutics Inc?
What is the 52-week high for Foghorn Therapeutics Inc?
What is the 52-week low for Foghorn Therapeutics Inc?
What is Foghorn Therapeutics Inc stock price today?
What was Foghorn Therapeutics Inc stock price yesterday?
What is the PE ratio of Foghorn Therapeutics Inc?
What is the Price-to-Book ratio of Foghorn Therapeutics Inc?
What is the 50-day moving average of Foghorn Therapeutics Inc?
How many employess does Foghorn Therapeutics Inc has?

Latest FHTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.